Acorda Therapeutics ACOR
$ 0.66
-24.86%
Quarterly report 2024-Q1
added 05-14-2024
Country |
USA |
IPO year |
2006 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Ron Cohen |
Employees in the company |
344 |
Shares |
1.24 M |
Market Cap[1] |
$ 820 K |
EBITDA (LTM) |
$ 533 K |
P/E (LTM) |
-0.02 |
P/S (LTM) |
0.01 |
EPS (LTM) |
-38.95 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.